UT Health Science Center-San Antonio: Mays Cancer Center Conducts Only Clinical Trial in America of a Specific Drug Combination for Lethal Brain Cancer Glioblastoma
May 24, 2023
May 24, 2023
SAN ANTONIO, Texas, May 24 (TNSjou) -- The University of Texas Health Science Center at San Antonio issued the following news release:
* * *
An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said.
* * *
The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glio . . .
* * *
An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said.
* * *
The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glio . . .